I’m confused on ur multiple choose “answers”
theres a video on Y O U T U B E helped me ace the health class a couple year ago
Food - increase in height
Predators - fast reproduction, fast in general
Heat/lack of water - Cam photosynthesis, storage of water
Predator/prey arms war - sensors along side to detect prey, sense of smell, etc
Answer:
b. The two bacterial strains have different phenotypes.
Explanation:
In genetics, the trait that is expressed is often referred to as the dominant trait and it can also be expresssed phenotypically.
Since one of the bacteria produces the inducer, it therefore means that bacteria has the dominant strain for the regulatory inducer while the other bacteria might have the strain but since it is not expressed phenotypically, it is as a result not dominant.
Phenotype refers to the physical appearance of an organism as a result of the interaction of its genes with the environment. Examples of phenotypic expresssions are hair colour, skin colour, height, etc.
The post-eradication era is a period of history for which there has been no precedent whatsoever in terms of a zero base of immunity. Cessation of immunization will eventually create a population susceptible to widespread infection in the event of accidental or intentional reintroduction or re-emergence of the eradicated virus. Thus, even after immunization ceases, vaccine production must continue.
However, many currently available vaccines may not be appropriate for continued post-eradication vaccine production or reinstatement. Vaccines must be continually improved and ongoing vaccination research maintained. Other potentially useful antiviral strategies—antivirals, prophylaxis, and probiotics—must also be considered as means to strengthen the immune system and serve as adjuvant or prophylactic therapies.
In the case of polio, for example, it remains to be determined which vaccine (oral polio vaccine [OPV] or inactivated polio vaccine [IPV]), or variant thereof, should be produced in the post-eradication, post-vaccination era. A detailed plan for vaccine production will require more information on OPV-derived viral persistence and transmission, as well as continuing dialogue between public health and research communities in order to ensure that appropriate vaccination research continues.
